In The Lancet Respiratory Medicine, Olivier Sitbon and colleagues1 present the results of a randomised, phase 2b clinical trial (ELEVATE-2) that compared the safety and efficacy of pulmonary arterial ...

Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Gossamer Bio (GOSS – Research Report) and keeping the price ...

and pulmonary hypertension may be particularly relevant to the pathophysiology heart failure in patients with preserved ejection fraction, there is compelling rationale for extending the ...

Increased funding and new public health policies for sickle cell research are needed to ease the burden on low-income nations ...

Oral supplements of carnitine were well tolerated and increased the blood levels of the molecule in people with PAH.

BACKGROUND: The European Chronic Thromboembolic Pulmonary Hypertension registry (CTEPH), conducted between 2007 and 2012, reported the major impact of pulmonary endarterectomy (PEA) on the long-term ...

New anecdotal evidence suggests some chemoimmunotherapy treatments may improve pulmonary arterial hypertension symptoms, but the overall evidence remains murky.

Hypertension is a compelling disease process that disproportionately affects African Americans. It is the single largest risk factor for cardiovascular disease in African Americans. The end organ ...

ECMO or ventilator use was the most significant predictor of mortality in patients undergoing lung transplant for idiopathic ...

Coarctation of the aorta is a congenital disease involving the cardiovascular system. The presentation can range from being ...

Older adults with untreated hypertension vs those with treated hypertension have a greater risk of developing Alzheimer disease.